Down-regulation of the apoptosis-inducing factor or Bcl-2 inhibitor of transcription by RNA interference can alleviate TAp63γ-induced apoptosis in esophageal squamous carcinoma EC9706 cells

International Journal of Oncology

Volumn 35, Issue 2, 2009, Pages 359-367

  Fan, Tianli ^a   Jiang, Guozhong ^a   Suo, Zhenhe ^b   Liu, Hongtao ^b   Xu, Peirong ^a   Ji, Zhenyu ^a   Zhang, Lirong ^a   Yang, Guanrui ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

AIF; Apoptosis; Bit1; Esophagus; TAp63

Indexed keywords

APOPTOSIS INDUCING FACTOR; BCL 2 INHIBITOR OF TRANSCRIPTION PROTEIN; MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN; PROTEIN TAP63 GAMMA; UNCLASSIFIED DRUG; BCL 2 INHIBITOR OF TRANSCRIPTION 1 PROTEIN, HUMAN; BCL-2 INHIBITOR OF TRANSCRIPTION 1 PROTEIN, HUMAN; CARBOXYLESTERASE; CASPASE; PROTEIN P53; TP63 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TRANSPORT; RNA INTERFERENCE; DRUG ANTAGONISM; ESOPHAGUS TUMOR; GENETICS; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; CARBOXYLIC ESTER HYDROLASES; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; HUMANS; MITOCHONDRIAL PROTEINS; RNA INTERFERENCE; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 69449090269     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000347     Document Type: Article

References (35)

1. Waltermann A, Kartasheva NN and Dobbelstein M: Differential regulation of p63 and p73 expression. Oncogene 22: 5686-5693, 2003.
2. Maisse C, Guerrieri P and Melino G: p73 and p63 protein stability: the way to regulate function? Biochem Pharmacol 66: 1555-1561, 2003.
3. Yang A, Kaghad M, Wang Y, et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316, 1998.
4. Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T and Lu X: ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol 24: 1341-1350, 2004.
5. Osada M, Ohba M, Kawahara C, et al: Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 4: 839-843, 1998.
6. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW and Jacks T: PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14: 704-718, 2000.
7. Ihrie RA, Reczek E, Horner JS, Khachatrian L, Sage J, Jacks T and Attardi LD: Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr Biol 13: 1985-1990, 2003.
8. Ihrie RA, Marques MR, Nguyen BT, et al: Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843-856, 2005.
9. Ihrie RA and Attardi LD: A new perp in the lineup: linking p63 and desmosomal adhesion. Cell Cycle 4: 873-876, 2005.
10. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD and Green DR: PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309: 1732-1735, 2005.
11. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303: 1010-1014, 2004.
12. Rosse T, Olivier R, Monney L, et al: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-499, 1998.
13. Tikhomirov O and Carpenter G: Bax activation and translocation to mitochondria mediate EGF-induced programmed cell death. J Cell Sci 118: 4681-4690, 2005.
14. Dohn M, Zhang S and Chen X: p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20: 3193-3205, 2001.
15. Cregan SP, Dawson VL and Slack RS: Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23: 2785-2796, 2004.
16. Cregan SP, Fortin A, MacLaurin JG, et al: Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 158: 507-517, 2002.
17. Arnoult D, Parone P, Martinou JC, Antonsson B, Estaquier J and Ameisen JC: Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 159: 923-929, 2002.
18. Arnoult D, Gaume B, Karbowski M, Sharpe JC, Cecconi F and Youle RJ: Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 22: 4385-4399, 2003.
19. Wang X, Yang C, Chai J, Shi Y and Xue D: Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298: 1587-1592, 2002.
20. Susin SA, Lorenzo HK, Zamzami N, et al: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446, 1999.
21. Jan Y, Matter M, Pai JT, et al: A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors. Cell 116: 751-762, 2004.
22. Yuan CQ, Li YN and Zhang XF: Down-regulation of apoptosis-inducing factor protein by RNA interference inhibits UVA-induced cell death. Biochem Biophys Res Commun 317: 1108-1113, 2004.
23. Levrero M, De laurenzi V, Costanzo A, Gong J, Wang JY and Melino G: The p53/p63/p73family of transcription factors: overlapping and distinct functions. J Cell Sci 113: 1661-1670, 2000.
24. Westfall MD, Mays DJ, Sniezek JC and Pietenpol JA: The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 23: 2264-2276, 2003.
25. Di Como CJ, Urist MJ, Babayan I, et al: p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 8: 494-501, 2002.
26. Hu H, Xia SH, Li AD, et al: Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 102: 580-583, 2002.
27. Lorenzo HK, Susin SA, Penninger J and Kroemer G: Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 6: 516-524, 1999.
28. Stupack DG and Cheresh DA: A Bit-role for integrins in apoptosis. Nat Cell Biol 6: 388-389, 2004.
29. Cory S, Huang DC and Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607, 2003.
30. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
31. Oda E, Ohki R, Murasawa H, et al: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058, 2000.
32. Willis SN and Adams JM: Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17: 617-625, 2005.
33. Willis SN, Chen L, Dewson G, et al: Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294-1305, 2005.
34. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC and Perucho M: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967-969, 1997.
35. Marsoni S and Damia G: Molecular targeting: new therapeutic strategies to improve tumour apoptosis. Ann Oncol 15: 229-231, 2004.